Antipsychotic drugs, also known as neuroleptics and tranquilizers, are a class of drugs used to treat schizophrenia or psychotic disorder. Antipsychotic drugs are used as a short or long-term treatments for bipolar disorder to control psychotic symptoms. Antipsychotics are also used as sedatives, in people with bipolar disorder, for anxiety, insomnia, and/or agitation. Often, these drugs are taken with a mood-stabilizing medication to manage symptoms of mania until mood stabilizers take full effect. Antipsychotic drugs are used to manage psychosis, particularly in schizophrenia, but also in various other psychotic disorders.
Antipsychotic drug, such as ziprasidone (Geodon), lurasidone (Latuda), clozapine (Clozaril), risperidone (Risperdal), quetiapine (Seroquel), olanzapine (Zyprexa), cariprazine (Vraylar), asenapine (Saphris), and aripiprazole (Abilify) are used to treat bipolar disorders. Moreover, antipsychotic drugs help control both the symptoms of depression and psychosis, respectively. They are currently the most common medication used in clinical medicine for the treatment of psychosis and schizophrenia. They have also been the mainstay of treatment for people with depression, bipolar disorder, and a number of anxiety and mood disorders.
Their use is so widespread because they are relatively safe and easy to prescribe, especially compared to the potentially serious side effects of alternative medications, including some used for treating drug abuse. Furthermore, antipsychotic drugs are used to manage hallucinations, disordered thought of paranoia, and delusions, among others. Antipsychotics are effective for the treatment of psychosis in a short duration. They are also used to treat people with psychosis that occurs in bipolar disorder, depression, and Alzheimer's disease. These drugs are often used in combination with other drugs to treat dementia, delirium, and mental health conditions.
Thus, with the increasing prevalence of aforementioned disorders worldwide, the demand for antipsychotic drugs is also increasing rapidly. For example, Germany is a leading figure in the battle against mental illness in Europe. According to borgenproject.org, Germany has similar rates of mental illness to other developed nations, with around 31% of Germans diagnosed with at least one mental illness. However, long-term use of these drugs may result in side effects such as involuntary movement disorder and metabolic syndrome, which may lead to increased mortality in geriatric population with dementia.
No comments:
Post a Comment